Works in Neuro-Oncology, 2023, Vol 25, Issue 6


Results: 22
    1

    Society News.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1198, doi. 10.1093/neuonc/noad077
    Publication type:
    Article
    2
    3
    4
    5

    What is a glioblastoma?

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1015, doi. 10.1093/neuonc/noad044
    By:
    • Lassman, Andrew B;
    • Bent, Martin J van den
    Publication type:
    Article
    6
    7
    8

    Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1123, doi. 10.1093/neuonc/noac262
    By:
    • Huntoon, Kristin;
    • Anderson, S Keith;
    • Ballman, Karla V;
    • Twohy, Erin;
    • Dooley, Katharine;
    • Jiang, Wen;
    • An, Yi;
    • Li, Jing;
    • Roemeling, Christina von;
    • Qie, Yaqing;
    • Ross, Owen A;
    • Cerhan, Jane H;
    • Whitton, Anthony C;
    • Greenspoon, Jeffrey N;
    • Parney, Ian F;
    • Ashman, Jonathan B;
    • Bahary, Jean-Paul;
    • Hadjipanayis, Constantinos;
    • Urbanic, James J;
    • Farace, Elana
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1017, doi. 10.1093/neuonc/noad002
    By:
    • Ellingson, Benjamin M;
    • Wen, Patrick Y;
    • Chang, Susan M;
    • van den Bent, Martin;
    • Vogelbaum, Michael A;
    • Li, Gang;
    • Li, Shanpeng;
    • Kim, Jiyoon;
    • Youssef, Gilbert;
    • Wick, Wolfgang;
    • Lassman, Andrew B;
    • Gilbert, Mark R;
    • Groot, John F de;
    • Weller, Michael;
    • Galanis, Evanthia;
    • Cloughesy, Timothy F
    Publication type:
    Article
    15
    16

    Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1085, doi. 10.1093/neuonc/noac285
    By:
    • Sampson, John H;
    • Achrol, Achal Singh;
    • Aghi, Manish K;
    • Bankiewicz, Krystof;
    • Bexon, Martin;
    • Brem, Steven;
    • Brenner, Andrew;
    • Chandhasin, Chandtip;
    • Chowdhary, Sajeel;
    • Coello, Melissa;
    • Ellingson, Benjamin M;
    • Floyd, John R;
    • Han, Seunggu;
    • Kesari, Santosh;
    • Mardor, Yael;
    • Merchant, Fahar;
    • Merchant, Nina;
    • Randazzo, Dina;
    • Vogelbaum, Michael;
    • Vrionis, Frank
    Publication type:
    Article
    17

    Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1100, doi. 10.1093/neuonc/noac253
    By:
    • Dean, Jamie A;
    • Tanguturi, Shyam K;
    • Cagney, Daniel;
    • Shin, Kee-Young;
    • Youssef, Gilbert;
    • Aizer, Ayal;
    • Rahman, Rifaquat;
    • Hammoudeh, Lubna;
    • Reardon, David;
    • Lee, Eudocia;
    • Dietrich, Jorg;
    • Tamura, Kaoru;
    • Aoyagi, Masaru;
    • Wickersham, Lacey;
    • Wen, Patrick Y;
    • Catalano, Paul;
    • Haas-Kogan, Daphne;
    • Alexander, Brian M;
    • Michor, Franziska
    Publication type:
    Article
    18
    19
    20
    21

    Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1113, doi. 10.1093/neuonc/noac263
    By:
    • Moreno, Victor;
    • Sepúlveda, Juan Manuel;
    • Reardon, David A;
    • Pérez-Núñez, Ángel;
    • León, Pedro González;
    • Hanna, Bishoy;
    • Filvaroff, Ellen;
    • Aronchik, Ida;
    • Chang, Henry;
    • Amoroso, Barbara;
    • Zuraek, Marlene;
    • Sanchez-Perez, Tania;
    • Mendez, Cristina;
    • Stephens, Daniel;
    • Nikolova, Zariana;
    • Vogelbaum, Michael A
    Publication type:
    Article
    22